Open Access

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma

  • Authors:
    • Yufeng Liu
    • Zhimin Zhang
    • Qing Li
    • Liang Zhang
    • Yi Cheng
    • Zhaoyang Zhong
  • View Affiliations

  • Published online on: June 4, 2020     https://doi.org/10.3892/or.2020.7633
  • Pages: 499-508
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Apurinic/apyrimidinic endonuclease 1 (APE1) is a primary nuclear‑localized multifunctional protein in osteosarcoma. However, the cytoplasmic localization of APE1 was found to be functional and to increase with cisplatin resistance, yet the molecular mechanism is unknown. In the present study, we explored the cisplatin resistance mechanism in osteosarcoma from the new perspective of APE1 extranuclear biological activity. Using cisplatin‑resistant and cisplatin‑sensitive osteosarcoma cell lines, we found that mitochondrial APE1 (mtAPE1) was overexpressed in cisplatin‑resistant cells but not in sensitive cells. Overexpression of mtAPE1 reduced cisplatin‑induced apoptosis, while knockdown of APE1 reversed this phenomenon and caused oxidative DNA damage via overproduction of reactive oxygen species (ROS). We further demonstrated that high mtAPE1 expression could downregulate ROS production by decreasing the phosphorylation of Rac1 (p‑Rac1), further promoting cisplatin resistance in osteosarcoma. Our findings suggest that mitochondrial APE1 promotes cisplatin resistance by decreasing ROS generation, which may provide new ideas for researching the molecular mechanism of osteosarcoma chemoresistance and strategies to overcome cisplatin resistance in osteosarcoma.

Related Articles

Journal Cover

August-2020
Volume 44 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Liu, Y., Zhang, Z., Li, Q., Zhang, L., Cheng, Y., & Zhong, Z. (2020). Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma. Oncology Reports, 44, 499-508. https://doi.org/10.3892/or.2020.7633
MLA
Liu, Y., Zhang, Z., Li, Q., Zhang, L., Cheng, Y., Zhong, Z."Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma". Oncology Reports 44.2 (2020): 499-508.
Chicago
Liu, Y., Zhang, Z., Li, Q., Zhang, L., Cheng, Y., Zhong, Z."Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma". Oncology Reports 44, no. 2 (2020): 499-508. https://doi.org/10.3892/or.2020.7633